In the last trading session, 0.19 million Virpax Pharmaceuticals Inc (NASDAQ:VRPX) shares changed hands as the company’s beta touched 0.94. With the company’s per share price at $0.33 changed hands at -$0.01 or -4.07% during last session, the market valuation stood at $2.59M. VRPX’s last price was a discount, traded about -1560.61% off its 52-week high of $5.48. The share price had its 52-week low at $0.29, which suggests the last value was 12.12% up since then. When we look at Virpax Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 1.61 million shares, with the 3-month average coming to 3.43 million.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
Instantly VRPX was in red as seen at the end of in last trading. With action -5.57%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -90.00%, with the 5-day performance at -5.57% in the red. However, in the 30-day time frame, Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is -43.53% down. Looking at the short shares, we see there were 0.35 million shares sold at short interest cover period of 1.04 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target for the stock as assigned by Wall Street analysts is 3, meaning bulls need an upside of 89.0% from its current market value. According to analyst projections, VRPX’s forecast low is 3 with 3 as the target high. To hit the forecast high, the stock’s price needs a -809.09% plunge from its current level, while the stock would need to soar -809.09% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -20.69%. The 2024 estimates are for Virpax Pharmaceuticals Inc earnings to increase by 74.56%.
VRPX Dividends
Virpax Pharmaceuticals Inc is expected to release its next quarterly earnings report in January.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.72% of Virpax Pharmaceuticals Inc shares while 1.90% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.97%. There are 1.90% institutions holding the Virpax Pharmaceuticals Inc stock share, with PARALLEL ADVISORS, LLC the top institutional holder. As of 2024-06-30, the company held 0.0001% of the shares, roughly 1.0 VRPX shares worth $1.0.
